SAN DIEGO, Sept. 21 /PRNewswire/ — Volcano Corporation (Nasdaq:
VOLC) today announced the company’s plans to launch Eagle
Eye® Platinum, PrimeWire PRESTIGE™, and the
s5™/s5i™ 3.2.1 Software at the Transcatheter
Cardiovascular Therapeutics (TCT) Meeting from September 21 – 25 in
Washington DC. These are three significant new product
innovations and updates to Volcano’s unique and innovative
intravascular product portfolio.
“Volcano’s commitment to listening to physicians and delivering
the innovative products they ask for will be evident again at this
year’s TCT with these three new product launches as well as our
excitement about our deep pipeline of new technologies which
includes Image Guided Therapy balloon and IVUS combination devices,
Optical Coherence Tomography (OCT), Forward Looking IVUS, Forward
Looking ICE, and Impact Microcatheters,” commented Scott
Huennekens, President and CEO of Volcano. “Volcano’s products have
now been used to help clinicians improve patient outcomes in over 1
million interventions. Our track record of innovation and
physician support has elevated Volcano to U.S. market leadership in
intravascular imaging. Our goal is to provide physicians with tools
that will improve patient outcomes and make PCI more efficient and
cost-effective. While health care cost concerns are top-of-mind,
Volcano innovates in an effort to serve reduce costs and improve
quality of care for patients.”
“At TCT this year, Volcano is launching three major new products
designed to make FFR and intravascular imaging faster and easier,”
said Joe Burnett, Executive Vice President of Marketing. “In an
economic environment that has challenged innovation, we are pleased
to be in a position where we can talk about not one, but three new
products. It is this track record of innovation, and our unique,
integrated system that combines
‘/>”/>
SOURCE
